Analyzing Risk Factors and Hematological Indices Associated with Helicobacter pylori Infection in Pediatric Patients

Insights

Poor socioeconomic conditions, hygiene, and family history are key risk factors for Helicobacter pylori (HP) infection in children with peptic ulcers. HP infection significantly alters blood routine indexes, impacting immune function.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Public Health

Background:

  • Peptic ulcers in children can be associated with Helicobacter pylori (HP) infection.
  • Identifying risk factors for HP infection is crucial for prevention and management in pediatric populations.
  • Understanding the impact of HP infection on hematological parameters is important for clinical assessment.

Purpose of the Study:

  • To identify independent risk factors for Helicobacter pylori (HP) infection in children diagnosed with peptic ulcers.
  • To investigate the association between HP infection and changes in routine blood test indexes in these children.

Main Methods:

  • A cohort of 173 children with peptic ulcers was studied.
  • Helicobacter pylori (HP) infection was detected using the 13C rapid urea breath test.
  • Routine blood tests and a questionnaire on hygiene and socioeconomic factors were administered.

Main Results:

  • Independent risk factors for HP infection included poor economic conditions, small living area, shared tableware, poor parental hygiene, and family history of ulcer.
  • HP-positive children showed significantly lower Red Blood Cell (RBC) count, Hemoglobin (Hb), and Hematocrit (HCT) levels.
  • HP-positive children exhibited a significantly higher platelet count compared to HP-negative children.

Conclusions:

  • Socioeconomic status, living conditions, hygiene practices, and family history are significant determinants of HP infection in children with peptic ulcers.
  • HP infection is associated with notable alterations in blood routine indexes, suggesting an impact on hematopoiesis and immune response.
  • These findings can inform targeted preventive strategies and clinical management of HP infection in pediatric peptic ulcer disease.
Abstract

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
959
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.4K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.4K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.4K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.7K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
722